课题基金 / 基金详情

GOALI: New Techniques for Solid-State NMR Studies of Pharmaceuticals

GOALI: New Techniques for Solid-State NMR Studies of Pharmaceuticals
GOALI:药物固态核磁共振研究新技术
批准号:
1265397
负责人:
Eric Munson
金额:
$1.13万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-18 至 2013-12-31

项目摘要

项目成果

Eric Munson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Professor Eric Munson of the University of Kansas and co-PI John Heinrich of Revolution NMR, LLC, are supported by the Analytical and Surface Chemistry Program in the Division of Chemistry (with co-funding from the GOALI program in the Engineering Directorate) to develop new techniques for solid-state Nuclear Magnetic Resonance (SSNMR) spectroscopy, and to apply those techniques to substances of pharmaceutical interest. They are collaborating with researchers from GlaxoSmithKline, who can provide insight into significant problems in the pharmaceutical industry and can help provide interesting compounds for study. This research aims for significant increases in sensitivity and throughput that will broaden the application of SSNMR in almost all fields of chemistry. Industrial collaborations will add value by promoting the rapid dissemination and application of technologies and information. They will also promote the rapid development of safe and efficacious drugs and drug formulations by increasing the number of drugs which can be analyzed, as well as identifying potential problems with proposed drug formulations. Finally, the interdisciplinary collaborative nature of the work will enhance the education of graduate students and postdoctoral associates performing and presenting this research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
I/UCRC Phase II: Collaborative Research: Center for Pharmaceutical Development (CPD)
  • 批准号:
    1939164
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $11.55万
  • 财政年份:
    2019
  • 负责人:
    Eric Munson
  • 依托单位:
I/UCRC Phase II: Collaborative Research: Center for Pharmaceutical Development (CPD)
Center for Pharmaceutical Development
Center for Pharmaceutical Development
海外基金